Friday, March 7, 2003
Welcome and Opening Remarks
CHAIRMAN KASS:The sessions this morning are devoted
to the topic of professional self-regulations in the field of laboratory
assisted reproduction. This is part of our project on the existing
regulation of uses of biomedical technologies touching the beginnings
of human life.
I just remind you we've embarked on this project partly growing
out of suggestions in the cloning report, partly following up on
our interest to see where in the existing system there is attention
to the kind of ethical questions that concern this council, and
we have decided to look at that intersection of assisted reproductive
technologies, the growing knowledge of human genetics and work in
developmental biology and embryo research.
We have in previous meetings looked at these issues as they are
dealt with by IRBs. At a previous meeting we heard from representatives,
from people commenting on the role of the FDA, and today at long
last we have an opportunity to go to the center of the discussion,
the profession and the industry surrounding this profession, which
is at the center of this work, the people who work in the area of
assisted reproductive technologies.